NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Worg Pharmaceuticals

Worg Pharmaceuticals

Private
HangzhouHealthcare & Life Scienceshttps://www.worgpharma.com/

Last Round

Series D

Extension

Dec 19, 2025

Total Funding Raised

$280.7M

Company Overview

Worg Pharmaceuticals is a biopharmaceutical company that develops next-generation specific immunotherapies for allergic and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

immunotherapyallergy immunotherapyAITautoimmune disease therapypeptide-based vaccineallergy diagnosticsprecision medicinebiopharmaceuticaldrug discoverybiotechclinical developmentallergy treatmentbiologicspharmaceutical licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Worg Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Worg Pharmaceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Worg Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series D ExtensionDec 19, 2025
Series DNov 20, 2024
Series CJul 11, 2023
Series BSep 15, 2022
Series AJan 18, 2021

Key People

Founding team and executive leadership

丁丁

CEO

Executive Team

Worg Pharmaceuticals Investors

Notable investors and investment history

Worg Pharmaceuticals investors
InvestorRounds
CITIC SecuritiesSeries B
Kaitai CapitalSeries A, Series B
Junson CapitalSeries B
Lapam CapitalSeries B
德同资本Series C
Mingfeng CapitalSeries D Extension
PICC Capital Equity Investment Co., Ltd.Series D, Series D Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2026

    Monthly visitors grew 40% MoM.

Worg Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Worg Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Worg Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range22
Year Founded2018
Last FundingDec 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.